1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Sonic Healthcare Limited
  6. News
  7. Summary
    SHL   AU000000SHL7

SONIC HEALTHCARE LIMITED

(SHL)
  Report
Delayed Australian Stock Exchange  -  05/24 11:50:21 pm EDT
36.57 AUD   +0.14%
05/24SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
05/23SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
04/27SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sonic Healthcare Limited Signs an Agreement with Harrison.ai to Form a Joint Venture Company

11/30/2021 | 04:15am EDT

Sonic Healthcare Limited (?Sonic?) announced that it has signed an agreement to form a Joint Venture (?JV?) company with Harrison.ai, to co-develop and commercialise effective and accurate clinical Artificial Intelligence (AI) solutions in pathology. In addition to forming the JV, Sonic Healthcare has taken a significant strategic shareholding in Harrison.ai. As one of the large providers of pathology /laboratory medicine in the world, the creation of this JV marks another positive step in Sonic's strategy to remain at the forefront of medical diagnostics. Based in Sydney, Harrison.ai is an internationally renowned company with a proven track record of building, validating and commercialising high-performance clinical AI tools at pace. With a team of more than 250 data scientists, engineers, and other staff across the group, Harrison.ai has developed clinical AI solutions in Imaging and IVF that already impact more than 50,000 patients each month and are approved for clinical use in Australia, UK, Europe and other countries. Harrison.ai and I-MED Radiology Network formed Annalise.ai in early 2020, a company that develops AI solutions for radiology. Sonic has entered into commercial arrangements with Annalise.ai to utilise its products, including Annalise CXR, which was developed and commercialised in just 18 months to become the world's most comprehensive AI clinical decision-support solution for chest X-rays. Annalise CXR was featured in peer-reviewed journal Lancet Digital Health as capable of detecting an unprecedented 124 findings in chest X-rays. Sonic is currently implementing the solution at more than 100 radiology clinics around Australia. With a shared vision to deliver high quality healthcare, the JV combines Harrison.ai's depth of expertise and comprehensive AI methodologies with Sonic Healthcare's clinical experience and distribution, to create new powerful AI applications to support clinicians to more effectively and efficiently diagnose patients in pathology.


© S&P Capital IQ 2021
All news about SONIC HEALTHCARE LIMITED
05/24SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
05/23SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
04/27SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
04/26SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
04/21SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
04/19SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
04/13SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
04/11SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
04/11SONIC HEALTHCARE : Application for quotation of securities - SHL
PU
03/31SONIC HEALTHCARE : Update - Notification of buy-back - SHL
PU
More news
Financials
Sales 2022 9 247 M 6 537 M 6 537 M
Net income 2022 1 437 M 1 016 M 1 016 M
Net Debt 2022 1 169 M 826 M 826 M
P/E ratio 2022 12,3x
Yield 2022 2,74%
Capitalization 17 346 M 12 262 M 12 262 M
EV / Sales 2022 2,00x
EV / Sales 2023 2,24x
Nbr of Employees 38 000
Free-Float 95,5%
Chart SONIC HEALTHCARE LIMITED
Duration : Period :
Sonic Healthcare Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SONIC HEALTHCARE LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 36,52 AUD
Average target price 38,46 AUD
Spread / Average Target 5,31%
EPS Revisions
Managers and Directors
Colin Stephen Goldschmidt Chief Executive Officer, MD & Executive Director
Christopher David Wilks CFO, Finance Director & Executive Director
Mark R. Compton Chairman
Louis James Panaccio Independent Non-Executive Director
Kathryn Dianne Spargo Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SONIC HEALTHCARE LIMITED-21.19%12 408
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-26.56%5 849
SYNLAB AG-28.33%3 982
DIAGNOSTICOS DA AMÉRICA S.A.-43.72%2 258
DR. LAL PATHLABS LIMITED-48.48%2 110
HEALIUS LIMITED-18.56%1 758